Azathioprine-induced interstitial pneumonitis in a patient with bullous pemphigoid
DOI:
https://doi.org/10.32818/reccmi.a10n3a13Keywords:
azathioprine, bullous pemphigoid, interstitial pneumonitisAbstract
We present the case of a patient with bullous pemphigoid who developed interstitial pneumonitis while receiving treatment with azathioprine. This side effect of azathioprine is very rare but has a significant impact on health. There are few published cases of azathioprine-induced pneumonitis, most of them in transplant patients, but in dermatology, a bibliographic search reveals only one published case in a patient with pemphigus. Early suspicion and immediate discontinuation of the drug are crucial for a favourable outcome.
Downloads
Metrics
References
Tan BB, Lear JT, Gawkrodger DJ, English JS. Azathioprine in dermatology: a survey of current practice in the UK. Br J Dermatol. 1997; 136: 351-55. Accesible en: https://pubmed.ncbi.nlm.nih.gov/9115914/ (último acceso dic. 2025). DOI: https://doi.org/10.1111/j.1365-2133.1997.tb14942.x
Stetter M, Schmidl M, Krapf R. Azathioprine hypersensivity mimicking Goodpasture‘s syndrome. Am J Kidney Dis .1994; 23(6): 874-77. doi: https://doi.org/10.1016/s0272-6386(12)80144-2 (último acceso dic. 2025). DOI: https://doi.org/10.1016/S0272-6386(12)80144-2
Wijsenbeek M, Suzuki A, Maher TH. Intersticial lung diseases. Lancet. 2022; 400(10354): 769-86. doi: https://doi.org/10.1016/S0140-6736(22)01052-2 (último acceso dic. 2025). DOI: https://doi.org/10.1016/S0140-6736(22)01052-2
Colome Pavón JA, Schoendor Ortega J, Borreguero E, Solache I. Neumonitis por amiodarona. An Med Interna. 1992; 9(3): 158.
Bodelier AG, Masclee AA, Bakker JA, Hameeteman WH, Pierik MJ. Azathioprine induced pneumonitis in a patient with ulcerative colitis. J Crohns Colitis. 2009;3(4): 309-312. doi: https://doi.org/10.1016/j.crohns.2009.07.003 (último acceso dic. 2025). DOI: https://doi.org/10.1016/j.crohns.2009.07.003
Lee IH, Kang GW, Kim KC. Hypersensitivity penumonitis associated whit azathioprine therapy in a patient wiht granulomatosis wiht polyangiitid. Rheumatol Int. 2016; 36(7): 1027-32. doi: https://doi.org/10.1007/s00296-016-3489-0 (último acceso dic. 2025). DOI: https://doi.org/10.1007/s00296-016-3489-0
Baughman RP, Meyer KC, Nathanson I, Angel L, Bhorade SM, Chan KM, et al. Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 142(5): e1S-e111S. doi: https://doi.org/10.1378/chest.12-1044 (último acceso dic. 2025). DOI: https://doi.org/10.1378/chest.12-1044
Johkoh T, Lee KS, Nishino M, Travis WD, Ryu JH, Lee HY, et al. Chest CT Diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society. Chest. 2021; 159(3): 1107-25. doi: https://doi.org/10.1016/j.chest.2020.11.027 (último acceso dic. 2025). DOI: https://doi.org/10.1016/j.chest.2020.11.027
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 María Jesús Bruscas-Alijarde, Anyuli Gracia-Gutiérrez, Leticia Royo-Trallero, Gloria Abad Tallada
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
